GRIN3A and Alzheimer disease: Additionally, our recent study verified that selective knockout of GluN3A in the cortex and hippocampus of young adult mice (3 months old) using the CRISPR/Cas9 method resulted in similar AD-like morphological and functional alterations 3–6 months later [225].